Last 12 months
Inside the activity.
12 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 6 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 4 | 0 |
| Sep 2026 | 2 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 08, 2023 Filed Dec 13, 2023 15:03 UTC Amendment |
Smith Lori BSVP Chief Information Officer
|
Exercise / conversionCommon Stock, $0.0001 par value | 4,698 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001261654-23-000131 · wk-form4a_1702479777.xml · nonDerivative · entry 1 Smith Lori B · CIK 0001799017 · SVP Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,672 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock. Read SEC document |
| December 08, 2023 Filed Dec 13, 2023 14:13 UTC |
Hitchcock Todd ASVP Chief Strategy & Transform
|
GrantPerformance Units · Derivative | 33,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000125 · wk-form4_1702476809.xml · derivative · entry 10 Hitchcock Todd A · CIK 0001799015 · SVP Chief Strategy & Transform 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,357 Underlying: Common Stock, $0.0001 par value · 33,357 shares Expires not disclosed F8 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2026 and 40% of which vest based on adjusted EBITDA for the fiscal year ending September 30, 2026. F8 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2026 and 40% of which vest based on adjusted EBITDA for the fiscal year ending September 30, 2026. F8 · derivative.expiration_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2026 and 40% of which vest based on adjusted EBITDA for the fiscal year ending September 30, 2026. Read SEC document |
| December 08, 2023 Filed Dec 13, 2023 14:13 UTC |
Hitchcock Todd ASVP Chief Strategy & Transform
|
GrantRestricted Stock Units · Derivative | 17,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000125 · wk-form4_1702476809.xml · derivative · entry 9 Hitchcock Todd A · CIK 0001799015 · SVP Chief Strategy & Transform 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,790 Underlying: Common Stock, $0.0001 par value · 17,790 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock. F7 · derivative.exercise_date: The restricted stock units vest in three equal installments beginning on December 8, 2024. F7 · derivative.expiration_date: The restricted stock units vest in three equal installments beginning on December 8, 2024. Read SEC document |
| December 08, 2023 Filed Dec 13, 2023 14:13 UTC |
Hitchcock Todd ASVP Chief Strategy & Transform
|
Exercise / conversionRestricted Stock Units · Derivative | 8,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000125 · wk-form4_1702476809.xml · derivative · entry 8 Hitchcock Todd A · CIK 0001799015 · SVP Chief Strategy & Transform 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,392 Underlying: Common Stock, $0.0001 par value · 8,695 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock. F6 · derivative.exercise_date: Vesting of restricted stock units granted on 12/08/2022. F6 · derivative.expiration_date: Vesting of restricted stock units granted on 12/08/2022. Read SEC document |
| December 08, 2023 Filed Dec 13, 2023 14:13 UTC |
Hitchcock Todd ASVP Chief Strategy & Transform
|
Exercise / conversionRestricted Stock Units · Derivative | 6,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000125 · wk-form4_1702476809.xml · derivative · entry 7 Hitchcock Todd A · CIK 0001799015 · SVP Chief Strategy & Transform 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,578 Underlying: Common Stock, $0.0001 par value · 6,577 shares Expires 2024-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock. F5 · derivative.exercise_date: Vesting of restricted stock units granted on 12/08/2021. F5 · derivative.expiration_date: Vesting of restricted stock units granted on 12/08/2021. Read SEC document |
| December 08, 2023 Filed Dec 13, 2023 14:13 UTC |
Hitchcock Todd ASVP Chief Strategy & Transform
|
Tax withholdingCommon Stock, $0.0001 par value | 2,118 | $11.88 | $25,161.84 |
DisclosureSEC source: 0001261654-23-000125 · wk-form4_1702476809.xml · nonDerivative · entry 4 Hitchcock Todd A · CIK 0001799015 · SVP Chief Strategy & Transform 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,230 F3 · price: Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 12/8/2022. Read SEC document |
| December 08, 2023 Filed Dec 13, 2023 14:13 UTC |
Hitchcock Todd ASVP Chief Strategy & Transform
|
Exercise / conversionCommon Stock, $0.0001 par value | 8,695 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001261654-23-000125 · wk-form4_1702476809.xml · nonDerivative · entry 3 Hitchcock Todd A · CIK 0001799015 · SVP Chief Strategy & Transform 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock. Read SEC document |
| December 08, 2023 Filed Dec 13, 2023 14:13 UTC |
Hitchcock Todd ASVP Chief Strategy & Transform
|
Tax withholdingCommon Stock, $0.0001 par value | 1,602 | $11.88 | $19,031.76 |
DisclosureSEC source: 0001261654-23-000125 · wk-form4_1702476809.xml · nonDerivative · entry 2 Hitchcock Todd A · CIK 0001799015 · SVP Chief Strategy & Transform 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,653 F2 · price: Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 12/08/2021. Read SEC document |
| December 08, 2023 Filed Dec 13, 2023 14:13 UTC |
Hitchcock Todd ASVP Chief Strategy & Transform
|
Exercise / conversionCommon Stock, $0.0001 par value | 6,577 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001261654-23-000125 · wk-form4_1702476809.xml · nonDerivative · entry 1 Hitchcock Todd A · CIK 0001799015 · SVP Chief Strategy & Transform 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock. Read SEC document |
| December 08, 2023 Filed Dec 13, 2023 14:04 UTC |
Smith Lori BSVP Chief Information Officer
|
GrantPerformance Units · Derivative | 17,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000123 · wk-form4_1702476238.xml · derivative · entry 10 Smith Lori B · CIK 0001799017 · SVP Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,790 Underlying: Common Stock, $0.0001 par value · 17,790 shares Expires not disclosed F8 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2026 and 40% of which vest based on adjusted EBITDA for the fiscal year ending September 30, 2026. F8 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2026 and 40% of which vest based on adjusted EBITDA for the fiscal year ending September 30, 2026. F8 · derivative.expiration_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2026 and 40% of which vest based on adjusted EBITDA for the fiscal year ending September 30, 2026. Read SEC document |
| December 08, 2023 Filed Dec 13, 2023 14:04 UTC |
Smith Lori BSVP Chief Information Officer
|
GrantRestricted Stock Units · Derivative | 9,488 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000123 · wk-form4_1702476238.xml · derivative · entry 9 Smith Lori B · CIK 0001799017 · SVP Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,488 Underlying: Common Stock, $0.0001 par value · 9,488 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock. F7 · derivative.exercise_date: The restricted stock units vest in three equal installments beginning on December 8, 2024. F7 · derivative.expiration_date: The restricted stock units vest in three equal installments beginning on December 8, 2024. Read SEC document |
| December 08, 2023 Filed Dec 13, 2023 14:04 UTC |
Smith Lori BSVP Chief Information Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 6,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000123 · wk-form4_1702476238.xml · derivative · entry 8 Smith Lori B · CIK 0001799017 · SVP Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,109 Underlying: Common Stock, $0.0001 par value · 6,374 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock. F6 · derivative.exercise_date: Vesting of restricted stock units granted on 12/08/2022. F6 · derivative.expiration_date: Vesting of restricted stock units granted on 12/08/2022. Read SEC document |
| December 08, 2023 Filed Dec 13, 2023 14:04 UTC |
Smith Lori BSVP Chief Information Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,698 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000123 · wk-form4_1702476238.xml · derivative · entry 7 Smith Lori B · CIK 0001799017 · SVP Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,698 Underlying: Common Stock, $0.0001 par value · 4,698 shares Expires 2024-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock. F5 · derivative.exercise_date: Vesting of restricted stock units granted on 12/08/2021. F5 · derivative.expiration_date: Vesting of restricted stock units granted on 12/08/2021. Read SEC document |
| December 08, 2023 Filed Dec 13, 2023 14:04 UTC |
Smith Lori BSVP Chief Information Officer
|
Tax withholdingCommon Stock, $0.0001 par value | 1,776 | $11.88 | $21,098.88 |
DisclosureSEC source: 0001261654-23-000123 · wk-form4_1702476238.xml · nonDerivative · entry 4 Smith Lori B · CIK 0001799017 · SVP Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,961 F3 · price: Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 12/8/2022. Read SEC document |
| December 08, 2023 Filed Dec 13, 2023 14:04 UTC |
Smith Lori BSVP Chief Information Officer
|
Exercise / conversionCommon Stock, $0.0001 par value | 6,374 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001261654-23-000123 · wk-form4_1702476238.xml · nonDerivative · entry 3 Smith Lori B · CIK 0001799017 · SVP Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,737 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock. Read SEC document |
| December 08, 2023 Filed Dec 13, 2023 14:04 UTC |
Smith Lori BSVP Chief Information Officer
|
Tax withholdingCommon Stock, $0.0001 par value | 1,309 | $11.88 | $15,550.92 |
DisclosureSEC source: 0001261654-23-000123 · wk-form4_1702476238.xml · nonDerivative · entry 2 Smith Lori B · CIK 0001799017 · SVP Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,363 F2 · price: Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 12/08/2021. Read SEC document |
| December 08, 2023 Filed Dec 13, 2023 14:04 UTC |
Smith Lori BSVP Chief Information Officer
|
Exercise / conversionCommon Stock, $0.0001 par value | 4,698 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001261654-23-000123 · wk-form4_1702476238.xml · nonDerivative · entry 1 Smith Lori B · CIK 0001799017 · SVP Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,672 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock. Read SEC document |
| December 08, 2023 Filed Dec 13, 2023 13:59 UTC |
Lorenz Tracy KayUTI Division President
|
GrantPerformance Units · Derivative | 26,685 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000121 · wk-form4_1702475938.xml · derivative · entry 2 Lorenz Tracy Kay · CIK 0001973341 · UTI Division President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,685 Underlying: Common Stock, $0.0001 par value · 26,685 shares Expires not disclosed F3 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2026 and 40% of which vest based on adjusted EBITDA for the fiscal year ending September 30, 2026. F3 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2026 and 40% of which vest based on adjusted EBITDA for the fiscal year ending September 30, 2026. F3 · derivative.expiration_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2026 and 40% of which vest based on adjusted EBITDA for the fiscal year ending September 30, 2026. Read SEC document |
| December 08, 2023 Filed Dec 13, 2023 13:59 UTC |
Lorenz Tracy KayUTI Division President
|
GrantRestricted Stock Units · Derivative | 14,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000121 · wk-form4_1702475938.xml · derivative · entry 1 Lorenz Tracy Kay · CIK 0001973341 · UTI Division President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,232 Underlying: Common Stock, $0.0001 par value · 14,232 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock. F2 · derivative.exercise_date: The restricted stock units vest in three equal installments beginning on December 8, 2024. F2 · derivative.expiration_date: The restricted stock units vest in three equal installments beginning on December 8, 2024. Read SEC document |
| September 28, 2023 Filed Oct 2, 2023 16:34 UTC |
Sanchez Loretta LydiaDirector
|
SaleCommon Stock, $0.0001 par value | 7,599 | $8.52 | $64,743.48 |
DisclosureSEC source: 0001261654-23-000094 · wk-form4_1696278845.xml · nonDerivative · entry 1 Sanchez Loretta Lydia · CIK 0001860681 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,930 F2 · price: The price reported in Column 4 represents the price per share on the date of sale. F1 · acquired: The Reporting Person's sale of shares was completed in connection with her financial planning needs, including for tax and estate planning purposes. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 22:05 UTC |
Fesperman BartSVP Chief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000092 · wk-form4_1695161145.xml · derivative · entry 3 Fesperman Bart · CIK 0001821616 · SVP Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.0001 par value · 3,778 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock. F4 · derivative.exercise_date: On September 15, 2020, the reporting person was granted restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On September 15, 2020, the reporting person was granted restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 22:05 UTC |
Fesperman BartSVP Chief Commercial Officer
|
Tax withholdingCommon Stock, $0.0001 par value | 996 | $8.47 | $8,436.12 |
DisclosureSEC source: 0001261654-23-000092 · wk-form4_1695161145.xml · nonDerivative · entry 2 Fesperman Bart · CIK 0001821616 · SVP Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,067 F3 · shares: Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 9/15/2020. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 22:05 UTC |
Fesperman BartSVP Chief Commercial Officer
|
Exercise / conversionCommon Stock, $0.0001 par value | 3,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000092 · wk-form4_1695161145.xml · nonDerivative · entry 1 Fesperman Bart · CIK 0001821616 · SVP Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Commons Stock received from vesting of restricted stock units granted on 9/15/2020. F2 · price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock. Read SEC document |
| June 23, 2023 Filed Jun 23, 2023 23:56 UTC |
Coliseum Capital Management, LLCDirector · 10% owner
Shackelton Christopher SDirector · 10% owner
Coliseum Capital, LLCDirector · 10% owner
COLISEUM CAPITAL PARTNERS, L.P.Director · 10% owner
Gray AdamDirector · 10% owner
|
PurchaseCommon Stock | 262,658 | $6.70 | $1,759,808.60 |
DisclosureSEC source: 0000899243-23-016436 · doc4.xml · nonDerivative · entry 3 Coliseum Capital Management, LLC · CIK 0001409751 · Director · 10% owner Shackelton Christopher S · CIK 0001430708 · Director · 10% owner Coliseum Capital, LLC · CIK 0001409585 · Director · 10% owner COLISEUM CAPITAL PARTNERS, L.P. · CIK 0001356974 · Director · 10% owner Gray Adam · CIK 0001454123 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 928,961 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.49 to $6.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The shares of Common Stock reported herein are held directly by (a) Coliseum Capital Partners, L.P. ("CCP"), an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser and (b) a separate account investment advisory client of CCM (the "Separate Account"). F5 · ownership.nature: Christopher Shackelton ("Shackelton") and Adam Gray ("Gray") are managers of and have an ownership interest in each of CCM and CC. Each of Shackelton, Gray, CCP, the Separate Account, CC and CCM disclaims beneficial ownership of these securities except to the extent of that person's pecuniary interest therein. F6 · ownership.nature: Following the transactions reported herein, CCP holds 749,183 shares of Common Stock and the Separate Account holds 179,778 shares of Common Stock. Read SEC document |
| June 22, 2023 Filed Jun 23, 2023 23:56 UTC |
Coliseum Capital Management, LLCDirector · 10% owner
Shackelton Christopher SDirector · 10% owner
Coliseum Capital, LLCDirector · 10% owner
COLISEUM CAPITAL PARTNERS, L.P.Director · 10% owner
Gray AdamDirector · 10% owner
|
PurchaseCommon Stock | 18,677 | $6.55 | $122,334.35 |
DisclosureSEC source: 0000899243-23-016436 · doc4.xml · nonDerivative · entry 2 Coliseum Capital Management, LLC · CIK 0001409751 · Director · 10% owner Shackelton Christopher S · CIK 0001430708 · Director · 10% owner Coliseum Capital, LLC · CIK 0001409585 · Director · 10% owner COLISEUM CAPITAL PARTNERS, L.P. · CIK 0001356974 · Director · 10% owner Gray Adam · CIK 0001454123 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 666,303 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.49 to $6.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The shares of Common Stock reported herein are held directly by (a) Coliseum Capital Partners, L.P. ("CCP"), an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser and (b) a separate account investment advisory client of CCM (the "Separate Account"). F5 · ownership.nature: Christopher Shackelton ("Shackelton") and Adam Gray ("Gray") are managers of and have an ownership interest in each of CCM and CC. Each of Shackelton, Gray, CCP, the Separate Account, CC and CCM disclaims beneficial ownership of these securities except to the extent of that person's pecuniary interest therein. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 23:56 UTC |
Coliseum Capital Management, LLCDirector · 10% owner
Shackelton Christopher SDirector · 10% owner
Coliseum Capital, LLCDirector · 10% owner
COLISEUM CAPITAL PARTNERS, L.P.Director · 10% owner
Gray AdamDirector · 10% owner
|
PurchaseCommon Stock, par value $0.0001 ("Common Stock") | 26,315 | $6.46 | $169,994.90 |
DisclosureSEC source: 0000899243-23-016436 · doc4.xml · nonDerivative · entry 1 Coliseum Capital Management, LLC · CIK 0001409751 · Director · 10% owner Shackelton Christopher S · CIK 0001430708 · Director · 10% owner Coliseum Capital, LLC · CIK 0001409585 · Director · 10% owner COLISEUM CAPITAL PARTNERS, L.P. · CIK 0001356974 · Director · 10% owner Gray Adam · CIK 0001454123 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 647,626 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.43 to $6.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The shares of Common Stock reported herein are held directly by (a) Coliseum Capital Partners, L.P. ("CCP"), an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser and (b) a separate account investment advisory client of CCM (the "Separate Account"). F5 · ownership.nature: Christopher Shackelton ("Shackelton") and Adam Gray ("Gray") are managers of and have an ownership interest in each of CCM and CC. Each of Shackelton, Gray, CCP, the Separate Account, CC and CCM disclaims beneficial ownership of these securities except to the extent of that person's pecuniary interest therein. Read SEC document |
| May 25, 2023 Filed Jun 1, 2023 01:10 UTC |
Lorenz Tracy KayUTI Division President
|
GrantRestricted Stock Units · Derivative | 22,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000083 · wf-form4_168558182212033.xml · derivative · entry 2 Lorenz Tracy Kay · CIK 0001973341 · UTI Division President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,699 Underlying: Common Stock, $0.0001 par value · 22,699 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock. F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on December 8, 2023. F3 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning on December 8, 2023. Read SEC document |
| May 25, 2023 Filed Jun 1, 2023 01:10 UTC |
Lorenz Tracy KayUTI Division President
|
GrantPerformance Units · Derivative | 42,561 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000083 · wf-form4_168558182212033.xml · derivative · entry 1 Lorenz Tracy Kay · CIK 0001973341 · UTI Division President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,561 Underlying: Common Stock, $0.0001 par value · 42,561 shares Expires not disclosed F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2025 and 40% of which vest based on adjusted EBITDA for the fiscal year ending September 30, 2025, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) immediately preceding and through grant date, and (ii) immediately preceding and through the 3rd anniversary of grant date (ending price). The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares. F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2025 and 40% of which vest based on adjusted EBITDA for the fiscal year ending September 30, 2025, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) immediately preceding and through grant date, and (ii) immediately preceding and through the 3rd anniversary of grant date (ending price). The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares. F1 · derivative.expiration_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2025 and 40% of which vest based on adjusted EBITDA for the fiscal year ending September 30, 2025, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) immediately preceding and through grant date, and (ii) immediately preceding and through the 3rd anniversary of grant date (ending price). The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares. Read SEC document |
| March 30, 2023 Filed Mar 30, 2023 23:49 UTC |
Coliseum Capital Management, LLCDirector · 10% owner
Shackelton Christopher SDirector · 10% owner
Coliseum Capital, LLCDirector · 10% owner
COLISEUM CAPITAL PARTNERS, L.P.Director · 10% owner
Gray AdamDirector · 10% owner
|
PurchaseCommon Stock | 112,390 | $6.97 | $783,358.30 |
DisclosureSEC source: 0000899243-23-010043 · doc4.xml · nonDerivative · entry 3 Coliseum Capital Management, LLC · CIK 0001409751 · Director · 10% owner Shackelton Christopher S · CIK 0001430708 · Director · 10% owner Coliseum Capital, LLC · CIK 0001409585 · Director · 10% owner COLISEUM CAPITAL PARTNERS, L.P. · CIK 0001356974 · Director · 10% owner Gray Adam · CIK 0001454123 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 621,311 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.84 to $7.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: The shares of Common Stock reported herein are held directly by (a) Coliseum Capital Partners, L.P. ("CCP"), an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser and (b) a separate account investment advisory client of CCM (the "Separate Account"). F2 · ownership.nature: Christopher Shackelton ("Shackelton") and Adam Gray ("Gray") are managers of and have an ownership interest in each of CCM and CC. Each of Shackelton, Gray, CCP, the Separate Account, CC and CCM disclaims beneficial ownership of these securities except to the extent of that person's pecuniary interest therein. F6 · ownership.nature: Following the transactions reported herein, CCP holds 502,482 shares of Common Stock and the Separate Account holds 118,829 shares of Common Stock. Read SEC document |
| March 29, 2023 Filed Mar 30, 2023 23:49 UTC |
Coliseum Capital Management, LLCDirector · 10% owner
Shackelton Christopher SDirector · 10% owner
Coliseum Capital, LLCDirector · 10% owner
COLISEUM CAPITAL PARTNERS, L.P.Director · 10% owner
Gray AdamDirector · 10% owner
|
PurchaseCommon Stock | 30,560 | $6.84 | $209,030.40 |
DisclosureSEC source: 0000899243-23-010043 · doc4.xml · nonDerivative · entry 2 Coliseum Capital Management, LLC · CIK 0001409751 · Director · 10% owner Shackelton Christopher S · CIK 0001430708 · Director · 10% owner Coliseum Capital, LLC · CIK 0001409585 · Director · 10% owner COLISEUM CAPITAL PARTNERS, L.P. · CIK 0001356974 · Director · 10% owner Gray Adam · CIK 0001454123 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 508,921 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.75 to $6.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: The shares of Common Stock reported herein are held directly by (a) Coliseum Capital Partners, L.P. ("CCP"), an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser and (b) a separate account investment advisory client of CCM (the "Separate Account"). F2 · ownership.nature: Christopher Shackelton ("Shackelton") and Adam Gray ("Gray") are managers of and have an ownership interest in each of CCM and CC. Each of Shackelton, Gray, CCP, the Separate Account, CC and CCM disclaims beneficial ownership of these securities except to the extent of that person's pecuniary interest therein. Read SEC document |
| March 28, 2023 Filed Mar 30, 2023 23:49 UTC |
Coliseum Capital Management, LLCDirector · 10% owner
Shackelton Christopher SDirector · 10% owner
Coliseum Capital, LLCDirector · 10% owner
COLISEUM CAPITAL PARTNERS, L.P.Director · 10% owner
Gray AdamDirector · 10% owner
|
PurchaseCommon Stock, par value $0.0001 ("Common Stock") | 6,282 | $6.74 | $42,340.68 |
DisclosureSEC source: 0000899243-23-010043 · doc4.xml · nonDerivative · entry 1 Coliseum Capital Management, LLC · CIK 0001409751 · Director · 10% owner Shackelton Christopher S · CIK 0001430708 · Director · 10% owner Coliseum Capital, LLC · CIK 0001409585 · Director · 10% owner COLISEUM CAPITAL PARTNERS, L.P. · CIK 0001356974 · Director · 10% owner Gray Adam · CIK 0001454123 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 478,361 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.71 to $6.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: The shares of Common Stock reported herein are held directly by (a) Coliseum Capital Partners, L.P. ("CCP"), an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser and (b) a separate account investment advisory client of CCM (the "Separate Account"). F2 · ownership.nature: Christopher Shackelton ("Shackelton") and Adam Gray ("Gray") are managers of and have an ownership interest in each of CCM and CC. Each of Shackelton, Gray, CCP, the Separate Account, CC and CCM disclaims beneficial ownership of these securities except to the extent of that person's pecuniary interest therein. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 16:25 UTC |
Kevane Christopher E.SVP Chief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,326 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000065 · wf-form4_167813790635305.xml · derivative · entry 3 Kevane Christopher E. · CIK 0001486632 · SVP Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.0001 par value · 3,326 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock. F4 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on March 2, 2021. F4 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 16:25 UTC |
Kevane Christopher E.SVP Chief Legal Officer
|
Tax withholdingCommon Stock, $0.0001 par value | 1,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000065 · wf-form4_167813790635305.xml · nonDerivative · entry 2 Kevane Christopher E. · CIK 0001486632 · SVP Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,918 F3 · shares: Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 3/2/2020. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 16:25 UTC |
Kevane Christopher E.SVP Chief Legal Officer
|
Exercise / conversionCommon Stock, $0.0001 par value | 3,326 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000065 · wf-form4_167813790635305.xml · nonDerivative · entry 1 Kevane Christopher E. · CIK 0001486632 · SVP Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,021 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Common Stock received from vesting of restricted stock units granted on 03/02/2020. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Common Stock. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 00:07 UTC |
Slubowski Michael A.Director
|
GrantCommon Stock, $0.0001 par value | 6,008 | $7.32 | $43,978.56 |
DisclosureSEC source: 0001261654-23-000061 · wf-form4_167780201219048.xml · nonDerivative · entry 1 Slubowski Michael A. · CIK 0001967317 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,008 F1 · shares: The shares were issued as non-employee director compensation under the Universal Technical Institute, Inc. 2021 Equity Incentive Plan and the award was approved by the Compensation Committee of UTI's Board of Directors on March 1, 2023. Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 13:42 UTC |
Sanchez Loretta LydiaDirector
|
GrantCommon Stock, $0.0001 par value | 9,895 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000050 · wf-form4_167717775119188.xml · nonDerivative · entry 1 Sanchez Loretta Lydia · CIK 0001860681 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,529 F1 · shares: The shares were issued as non-employee director compensation under the Universal Technical Institute, Inc. 2021 Equity Incentive Plan and the award was approved by the Compensation Committee of UTI's Board of Directors on February 22, 2023. Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 18:43 UTC |
Brochick George W.Director
|
GrantCommon Stock, $0.0001 par value | 9,895 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000052 · wf-form4_167717778937470.xml · nonDerivative · entry 1 Brochick George W. · CIK 0001807493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,128 F1 · shares: The shares were issued as non-employee director compensation under the Universal Technical Institute, Inc. 2021 Equity Incentive Plan and the award was approved by the Compensation Committee of UTI's Board of Directors on February 22, 2023. Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 18:43 UTC |
DEVINCENZI ROBERT THOMASDirector
|
GrantCommon Stock, $0.0001 par value | 9,895 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000053 · wf-form4_167717780936503.xml · nonDerivative · entry 1 DEVINCENZI ROBERT THOMAS · CIK 0001226186 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,663 F1 · shares: The shares were issued as non-employee director compensation under the Universal Technical Institute, Inc. 2021 Equity Incentive Plan and the award was approved by the Compensation Committee of UTI's Board of Directors on February 22, 2023. Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 18:43 UTC |
Okinaka Shannon LeiDirector
|
GrantCommon Stock, $0.0001 par value | 9,895 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000051 · wf-form4_167717776848597.xml · nonDerivative · entry 1 Okinaka Shannon Lei · CIK 0001631318 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,141 F1 · shares: The shares were issued as non-employee director compensation under the Universal Technical Institute, Inc. 2021 Equity Incentive Plan and the award was approved by the Compensation Committee of UTI's Board of Directors on February 22, 2023. Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 18:42 UTC |
TRAMMELL KENNETH RDirector
|
GrantCommon Stock, $0.0001 par value | 9,895 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000049 · wf-form4_167717773167783.xml · nonDerivative · entry 1 TRAMMELL KENNETH R · CIK 0001239782 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,416 F1 · shares: The shares were issued as non-employee director compensation under the Universal Technical Institute, Inc. 2021 Equity Incentive Plan and the award was approved by the Compensation Committee of UTI's Board of Directors on February 22, 2023. Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 18:42 UTC |
Blaszkiewicz DavidDirector
|
GrantCommon Stock, $0.0001 par value | 9,895 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000048 · wf-form4_167717771225773.xml · nonDerivative · entry 1 Blaszkiewicz David · CIK 0001536971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,934 F1 · shares: The shares were issued as non-employee director compensation under the Universal Technical Institute, Inc. 2021 Equity Incentive Plan and the award was approved by the Compensation Committee of UTI's Board of Directors on February 22, 2023. Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 18:41 UTC |
SRERE LINDA JDirector
|
GrantCommon Stock, $0.0001 par value | 9,895 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000047 · wf-form4_167717767571873.xml · nonDerivative · entry 1 SRERE LINDA J · CIK 0001193863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,897 F1 · shares: The shares were issued as non-employee director compensation under the Universal Technical Institute, Inc. 2021 Equity Incentive Plan and the award was approved by the Compensation Committee of UTI's Board of Directors on February 22, 2023. Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 18:37 UTC |
LENNOX WILLIAM J JRDirector
|
GrantCommon Stock, $0.0001 par value | 9,895 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000039 · wf-form4_167717742458598.xml · nonDerivative · entry 1 LENNOX WILLIAM J JR · CIK 0001597376 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,301 F1 · shares: The shares were issued as non-employee director compensation under the Universal Technical Institute, Inc. 2021 Equity Incentive Plan and the award was approved by the Compensation Committee of UTI's Board of Directors on February 22, 2023. Read SEC document |
| January 07, 2023 Filed Jan 11, 2023 00:29 UTC |
Smith SherrellEVP, Campus Ops & Services
|
Exercise / conversionRestricted Stock Units · Derivative | 6,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000021 · wf-form4_167339694607319.xml · derivative · entry 3 Smith Sherrell · CIK 0001371105 · EVP, Campus Ops & Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.0001 par value · 6,013 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock. F4 · derivative.exercise_date: Shares of Common Stock received from vesting of restricted stock units granted on 1/7/2020. F4 · derivative.expiration_date: Shares of Common Stock received from vesting of restricted stock units granted on 1/7/2020. Read SEC document |
| January 07, 2023 Filed Jan 11, 2023 00:29 UTC |
Smith SherrellEVP, Campus Ops & Services
|
Tax withholdingCommon Stock, $0.0001 par value | 2,816 | $6.71 | $18,895.36 |
DisclosureSEC source: 0001261654-23-000021 · wf-form4_167339694607319.xml · nonDerivative · entry 2 Smith Sherrell · CIK 0001371105 · EVP, Campus Ops & Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,055 F3 · shares: Shares withheld to satisfy tax liability for the vesting of performance units granted on 1/7/2020. Read SEC document |
| January 07, 2023 Filed Jan 11, 2023 00:29 UTC |
Smith SherrellEVP, Campus Ops & Services
|
Exercise / conversionCommon Stock, $0.0001 par value | 6,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000021 · wf-form4_167339694607319.xml · nonDerivative · entry 1 Smith Sherrell · CIK 0001371105 · EVP, Campus Ops & Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,871 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On January 7, 2020, the reporting person was granted restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Common Stock. Read SEC document |
| January 07, 2023 Filed Jan 11, 2023 00:29 UTC |
Anderson Troy REVP and CFO
|
Exercise / conversionRestricted Stock Units · Derivative | 10,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000020 · wf-form4_167339692529534.xml · derivative · entry 3 Anderson Troy R · CIK 0001789633 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.0001 par value · 10,222 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock. F4 · derivative.exercise_date: Shares of Common Stock received from vesting of restricted stock units granted on 1/7/2020. F4 · derivative.expiration_date: Shares of Common Stock received from vesting of restricted stock units granted on 1/7/2020. Read SEC document |
| January 07, 2023 Filed Jan 11, 2023 00:29 UTC |
Anderson Troy REVP and CFO
|
Tax withholdingCommon Stock, $0.0001 par value | 3,389 | $6.71 | $22,740.19 |
DisclosureSEC source: 0001261654-23-000020 · wf-form4_167339692529534.xml · nonDerivative · entry 2 Anderson Troy R · CIK 0001789633 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,660 F3 · shares: Shares withheld to satisfy tax liability for the vesting of performance units granted on 1/7/2020. Read SEC document |
| January 07, 2023 Filed Jan 11, 2023 00:29 UTC |
Anderson Troy REVP and CFO
|
Exercise / conversionCommon Stock, $0.0001 par value | 10,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000020 · wf-form4_167339692529534.xml · nonDerivative · entry 1 Anderson Troy R · CIK 0001789633 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On January 7, 2020, the reporting person was granted restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Common Stock. Read SEC document |
| January 07, 2023 Filed Jan 11, 2023 00:28 UTC |
Grant Jerome AlanDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 23,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001261654-23-000019 · wf-form4_167339690801833.xml · derivative · entry 3 Grant Jerome Alan · CIK 0001723537 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.0001 par value · 23,570 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock. F4 · derivative.exercise_date: On January 7, 2020, the reporting person was granted restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On January 7, 2020, the reporting person was granted restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.